Earnings Release • Mar 26, 2025
Earnings Release
Open in ViewerOpens in native device viewer

March 26th, 2025
| 2023 | 2024 | Change | |
|---|---|---|---|
| Sales | 62.274.595 | 66.199.508 | 6% |
| Gross profit | 21.239.054 | 24.690.394 | 16% |
| Earnings before interest, taxes, depreciation and amortization (EBITDA) |
9.216.593 | 10.587.411 | 15% |
| Profit before tax | 5.035.351 | 6.052.380 | 20% |
| Profit after tax | 4.081.318 | 5.273.523 | 29% |
In the year 2024, the Company's turnover amounted to EUR 66.2 million (compared to EUR 62.3 million in the corresponding period of 2023), an increase of 6.3%, with the value of exports representing 55% of total turnover.

.
Regarding the contribution of the four business segments to the 2024 turnover, 30% of the total revenue comes from sales of PAPOUTSANIS branded products in Greece and abroad, 17% from sales to the hotel market, 36% from third party manufacturing and 17% from sales of specialty soap bases.
In 2024, there was an improvement in all the Company's profitability indicators. More specifically, gross margin reached EUR 24.7 million compared to EUR 21.2 million, an improvement of 16% thanks to the greater contribution of branded products in the retail and hotel market to total sales, as well as the completion of the strong investment plan of the previous years. As a result, a significant reduction in industrialisation costs has been achieved while boosting turnover growth prospects through new agreements as there is the potential to offer higher quality products at competitive prices. The completion of the strong investment plan of recent years has created the necessary free capacity (approximately 50% on average), setting the right conditions for new partnerships. The Company has already agreed with existing and new customers, new projects which will be implemented within 2025 and will further enhance its turnover and profitability.
Gross profit in FY 2024 amounted to EUR 24.7 million compared to EUR 21.2 million in FY 2023, improved by 16% thanks to the higher contribution of branded products in the retail and hotel market to total turnover, as well as the reduction in production costs resulting from the investment plan of the previous years. Gross profit margin was 37% compared to 34% in 2023.
The Company's distribution, administrative and research and development expenses amounted to EUR 17.3 million in FY 2024 compared to EUR 14.6 million in FY 2023, representing an increase of 19%, mainly due to the enhanced promotion and promotional plan of Papoutsanis' branded retail products to support the strong growth of this strategic pillar and the Company's entry into new, large categories such as home care.
Earnings before interest, taxes, depreciation and amortization amounted to EUR 10.6 million compared to EUR 9.2 million in 2023, up 15%. EBITDA is the sum of earnings before tax, net finance costs, depreciation and amortisation and grant's depreciation.
The Company's profit before tax amounted to EUR 6.1 million, compared to a profit of EUR 5.0 million in 2023, an improvement of 20%. Profit after tax amounted to EUR 5.3 million compared to a profit of EUR 4.1 million in 2023, improved by 29%.
Branded Products: This category shows strong growth of 17% compared to 2023, primarily driven by the ARKADI brand (+69% vs. 2023), and exports (+22% vs. 2023). Excluding the aforementioned areas, sales of PAPOUTSANIS branded products show

6% growth compared to 2023, more than offsetting the decline in the antiseptic category (-14% compared to 2023), thanks to the enrichment of the product portfolio with innovative products, entry into important new categories, dynamic promotional support and further strengthening of distribution and product image in stores.
Hotel Products: Sales in this category increased by 3.5% in 2024, with the main contributor being the PAPOUTSANIS branded hotel products sales. At the same time, third-party hotel product sales abroad maintained 2023 levels, reversing the first half downward trend in 2024, which was due to a high base in the previous year.
In particular, sales of Papoutsanis branded hotel products increased by 9%, driven by exports, which achieved a strong double-digit rate in 2024 (+53%) compared to 2023, creating the base for further strengthening Papoutsanis hotel amenities abroad. Domestic sales of PAPOUTSANIS branded hotel products maintained 2023 levels, increasing by 1%.
Third party contract manufacturing sales were at satisfactory levels and closed 2024 down 2.8% compared to 2023 having covered most of the first half of the year (-10% year-on-year), as significant new partnerships started to pay off. In particular, the category strengthened in the second half of 2024, following the launch of a partnership with a major multinational, with a new product portfolio gradually developed during the year, while building a strong base for 2025 as the partnership is in full swing.
Industrial soap sales: In the soap bases category, sales increased by 14% compared to 2023, driven by the expansion of partnerships and product ranges. The Company's goal remains to continuously expand its customer base and further develop its synthetic soap bases.
Outside factors affecting the environment in which Papoutsanis operates remain volatile. In this context, the Company has developed strategies and tactics to further improve both profitability and turnover, such as:

For the year 2025, the Company aims to develop the activity and improve profitability. In particular, the Company expects double-digit growth in turnover, as a result of the expansion of existing ones and the launch of significant new partnerships in the pillars of third-party producers and industrial soap noodles. In addition, a significant further strengthening of the branded products category is expected, as already from 2024

Papoutsanis has expanded into the home care category in addition to personal care products, in which it has traditionally been active for decades.
More specifically per category:
The Management intends to propose to the Annual General Meeting of Shareholders the distribution of a dividend of a gross amount of €0,03 per share.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.